Literature DB >> 29313311

The Safety of Generic Prescription Drugs in the United States.

Sonal Singh1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29313311     DOI： 10.1007/s40264-017-0632-0

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  17 in total

1.  Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014.

Authors:  Thomas J Moore; Curt D Furberg; Donald R Mattison; Michael R Cohen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-02-10       Impact factor: 2.890

2.  Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.

Authors:  Barbara M Davit; Patrick E Nwakama; Gary J Buehler; Dale P Conner; Sam H Haidar; Devvrat T Patel; Yongsheng Yang; Lawrence X Yu; Janet Woodcock
Journal:  Ann Pharmacother       Date:  2009-09-23       Impact factor: 3.154

3.  Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugs.

Authors:  J Bohn; C Kortepeter; M Muñoz; K Simms; S Montenegro; G Dal Pan
Journal:  Clin Pharmacol Ther       Date:  2015-04-03       Impact factor: 6.875

Review 4.  Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews.

Authors:  Oluwadamilola Onasanya; Geetha Iyer; Eleanor Lucas; Dora Lin; Sonal Singh; G Caleb Alexander
Journal:  Lancet Diabetes Endocrinol       Date:  2016-09-23       Impact factor: 32.069

5.  Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs.

Authors:  Ning Cheng; Md Motiur Rahman; Yasser Alatawi; Jingjing Qian; Peggy L Peissig; Richard L Berg; C David Page; Richard A Hansen
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

6.  Differences in Adverse Event Reporting Rates of Therapeutic Failure Between Two Once-daily Extended-release Methylphenidate Medications in Canada: Analysis of Spontaneous Adverse Event Reporting Databases.

Authors:  Laura Park-Wyllie; Judy van Stralen; Genaro Castillon; Stephen E Sherman; Doron Almagor
Journal:  Clin Ther       Date:  2017-10-06       Impact factor: 3.393

7.  Patient-relevant outcomes associated with generic tamsulosin, levothyroxine and amphetamine in the FDA Adverse Event Reporting System: a pilot study.

Authors:  Sathiya Priya Marimuthu; Geetha Iyer; Jodi B Segal; Sonal Singh
Journal:  J Comp Eff Res       Date:  2017-07-07       Impact factor: 1.744

8.  An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System.

Authors:  Geetha Iyer; Sathiya Priya Marimuthu; Jodi B Segal; Sonal Singh
Journal:  Drug Saf       Date:  2017-09       Impact factor: 5.228

9.  Use of the analytic hierarchy process for medication decision-making in type 2 diabetes.

Authors:  Nisa M Maruthur; Susan M Joy; James G Dolan; Hasan M Shihab; Sonal Singh
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

Review 10.  What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs.

Authors:  Suzanne S Dunne; Colum P Dunne
Journal:  BMC Med       Date:  2015-07-29       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.